Skip to main content

Month: April 2022

TFI International to Hold Annual and Special Meeting of Shareholders and Report First Quarter Results

MONTREAL, April 07, 2022 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced that it will hold an Annual and Special Meeting of shareholders on Thursday, April 28, 2022 at 1:30 p.m. (Eastern Time) at the Company’s head office, 8801 Trans-Canada Highway, Suite 500, Saint-Laurent, Quebec. The meeting will also be available by way of telephone conference call. The dial-in number for the meeting is 877-223-4471. Shareholders are asked to participate in the meeting by telephone and to vote their shares prior to the meeting by returning their proxy form or voting instruction form, voting online or using the toll-free telephone number set out on the proxy or voting instruction form. During the telephone meeting, shareholders will be able...

Continue reading

Report from the Annual General Meeting of Olink Holding AB (publ) on 7 April 2022

UPPSALA, Sweden, April 07, 2022 (GLOBE NEWSWIRE) — At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189–7755, (the “Company”), on 7 April 2022 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website, www.olink.com. Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liabilityThe AGM adopted the Company’s income statement and balance sheet and the consolidated income statement and consolidated balance sheet. The AGM resolved to dispose the Company’s results in accordance with the Board of Directors’ proposal,...

Continue reading

Option Care Health to Announce First Quarter 2022 Financial Results and Host Conference Call

BANNOCKBURN, Ill., April 07, 2022 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2022 on Thursday, April 28, 2022 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing (866) 360-3136 and referencing conference ID 5737323; or via a live audio webcast that will be available online at https://investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same...

Continue reading

Report from the Annual General Meeting of Olink Holding AB (publ) on 7 April 2022

UPPSALA, Sweden, April 07, 2022 (GLOBE NEWSWIRE) — At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 7 April 2022 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website, www.olink.com. Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liabilityThe AGM adopted the Company’s income statement and balance sheet and the consolidated income statement and consolidated balance sheet. The AGM resolved to dispose the Company’s results in accordance with the Board of Directors’ proposal, whereby...

Continue reading

Corcept Therapeutics Announces Appointment of Three Senior Leaders

Key Hires Bring Diverse Expertise to Commercial and Development Initiatives MENLO PARK, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the effects of the hormone cortisol, today announced the appointment of three individuals to Commercial and Development leadership roles. Daniel Einhorn, MD, FACP, FACE, has joined Corcept as Vice President, Endocrine Strategy; Amiel Balagtas has joined as Vice President, Development Operations; and Lyndah Dreiling, MD, has joined as Vice President, Global Oncology Development. Dr. Einhorn will report to Sean Maduck, President of Corcept Endocrinology. Mr. Balagtas and Dr. Dreiling will report...

Continue reading

Runway Growth Finance Provides First Quarter 2022 Portfolio Update

Completed Seven Investments in New and Existing Portfolio Companies Representing $135 Million in New Commitments and $83.5 Million in Funded Loans Total Loan Commitments and Funded Investments Grow To $1.6 Billion and $1.3 Billion Since InceptionWOODSIDE, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (“Runway Growth”) (Nasdaq: RWAY), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced a portfolio update for the first quarter ended March 31, 2022. “Runway Growth capitalized on its strong momentum in the first quarter, utilizing proceeds from our revolving credit facility to complete seven new investments, strategically increase leverage and drive strong portfolio growth amidst increasing market uncertainty,” said...

Continue reading

Kura Sushi USA Announces Fiscal Second Quarter 2022 Financial Results

IRVINE, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today reported fiscal second quarter 2022 financial results for the period ended February 28, 2022. Fiscal Second Quarter 2022 Highlights        Total sales were $31.3 million compared to $9.1 million in the second quarter of 2021; Comparable restaurant sales increased 183% for the second quarter of 2022 as compared to the second quarter of 2021 and increased 11.3% as compared to the second quarter of 2020; Operating loss was $1.9 million, compared to an operating loss of $3.8 million in the second quarter of 2021; Net loss was $1.9 million, or ($0.19) per diluted share, compared to net loss of $3.9 million, or ($0.46) per diluted share, in the second quarter...

Continue reading

Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update

Dosed first patient in the Phase 1 trial of DeTIL-0255, Nurix’s drug-enhanced tumor infiltrating lymphocyte (TIL) program Awarded Innovation Passport for Entry into Innovative Licensing and Access Pathway (ILAP) in the United Kingdom for NX-1607 Reports strong financial position with $385.7 million in cash and investments as of February 28, 2022 SAN FRANCISCO, April 07, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs, today reported financial results for the first quarter ended February 28, 2022 and provided a corporate update. “In the first quarter, we have made both clinical and regulatory advances in each of our four drug programs including our lead BTK degrader NX-2127 which position us well to provide important proof of...

Continue reading

Toll Brothers Debuts Sterling Grove Clubhouse and Amenity Center

Highly Anticipated 20,000 Square Foot Clubhouse and 10-acre Amenity Center are Now OpenToll Brothers Sterling Grove Clubhouse and Amenity Center The Highly Anticipated 20,000 Square Foot Clubhouse and 10-acre Amenity Center are Now OpenToll Brothers Sterling Grove Clubhouse and Amenity Center Ribbon Cutting Toll Brothers celebrated the opening of the 20,000-square-foot clubhouse and 10-acre amenity center at its Sterling Grove community in Surprise, Ariz. Pictured (left to right): John DePaul, Toll Brothers; Jessica Walls-Randall, Sterling Grove; Bob Flaherty, Toll Brothers; Skip Hall, City of Surprise; Major Danny LaCore, Luke Air Force; Dan Rhea, Toll Brothers; Ryan Stemsrud, Troon; Charlie Crawford, Toll Brothers; Devin Hobbs, Toll Brothers.SURPRISE, Ariz., April 07, 2022 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL),...

Continue reading

Comscore and Tremor International Partner to Deliver Expanded Programmatic CTV Audience Engagement

Comscore’s Predictive Audience solution will bring privacy-friendly and contextual audience curation to Tremor Video and Unruly campaigns RESTON, Va. and NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) — Comscore (Nasdaq: SCOR), a trusted partner for planning, transacting, and evaluating media across platforms, today announced an agreement with Tremor International Ltd. (AIM/NASDAQ: TRMR), a global leader in video and Connected TV (“CTV”) advertising, offering an end-to-end technology platform that enables advertisers to reach relevant audiences and publishers to maximize yield on their digital advertising inventory. Under the agreement, Comscore’s next generation cookie-free Predictive Audiences are now available for activation across Tremor International’s end-to-end platform, which encompasses the Tremor Video DSP and the Unruly...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.